Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-27 Sale | 2022-07-29 4:18 pm | Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer | 1,183 | $74.94 | $88,654 | 28,700 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:10 pm | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 397 | $36.3 | $14,411 | 65,848 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:09 pm | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 221 | $36.3 | $8,022 | 96,961 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:09 pm | Turning Point Therapeutics Inc. | TPTX | North Annette EVP & General Counsel | 669 | $36.3 | $24,285 | 86,579 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:08 pm | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP & Chief Medical Officer | 669 | $36.3 | $24,285 | 109,188 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:07 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 2,971 | $36.3 | $107,847 | 334,970 (Direct) | View |
| 2021-08-30 Sale | 2021-08-31 5:26 pm | Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. | 10,000 | $80 | $800,000 | 156,974 (Direct) | View |
| 2021-07-14 Sale | 2021-07-15 5:53 pm | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 1,869 | $74.9 | $139,988 | 21,767 (Direct) | View |
| 2021-06-21 Purchase | 2021-06-21 9:14 pm | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 2,000 | $81.34 | $162,680 | 2,000 (Direct) | View |
| 2021-06-15 Sale | 2021-06-16 5:16 pm | Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. | 15,000 | $77.03 | $1,155,433 | 166,974 (Direct) | View |
| 2021-03-23 Sale | 2021-03-24 9:54 pm | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. | 28,435 | $100.65 | $2,862,082 | 32,443 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-17 Disposition | 2022-08-17 4:43 pm | N/A 2030-01-21 | Turning Point Therapeutics Inc. | TPTX | Nicholson Garry A Director | 31,900 | $0 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:41 pm | N/A 2029-05-12 | Turning Point Therapeutics Inc. | TPTX | Machado Patrick Director | 47,000 | $0 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:40 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | George Simeon Director | 2,253,660 | $76 | 0 (Indirect) | View |
| 2022-08-17 Disposition | 2022-08-17 4:40 pm | N/A 2029-04-21 | Turning Point Therapeutics Inc. | TPTX | George Simeon Director | 32,000 | $0 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:38 pm | N/A 2030-06-14 | Turning Point Therapeutics Inc. | TPTX | Gallagher Carol Giltner Director | 47,000 | $0 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:37 pm | N/A 2031-03-30 | Turning Point Therapeutics Inc. | TPTX | Bodem Barbara W. Director | 14,995 | $0 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:32 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 2,000 | $76 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:32 pm | N/A 2031-05-23 | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 17,209 | $0 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:31 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer | 29,778 | $76 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:31 pm | N/A 2031-07-25 | Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer | 119,800 | $0 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:29 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Sun Brian SVP & General Counsel | 45,000 | $76 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:29 pm | N/A 2032-04-10 | Turning Point Therapeutics Inc. | TPTX | Sun Brian SVP & General Counsel | 195,000 | $0 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:27 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Sabus Steve M SVP & Chief Commercial Officer | 36,667 | $76 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:27 pm | N/A 2032-05-30 | Turning Point Therapeutics Inc. | TPTX | Sabus Steve M SVP & Chief Commercial Officer | 165,000 | $0 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:26 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 41,284 | $76 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:26 pm | N/A 2029-12-01 | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 266,734 | $0 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:23 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 110,959 | $76 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:23 pm | N/A 2028-06-05 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 2,038,194 | $0 | 0 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-01 5:02 pm | N/A 2032-05-30 | Turning Point Therapeutics Inc. | TPTX | Sabus Steve M SVP & Chief Commercial Officer | 201,667 | $0 | 201,667 (Direct) | View |
| 2022-04-11 Option Award | 2022-04-12 6:46 pm | N/A 2032-04-10 | Turning Point Therapeutics Inc. | TPTX | Sun Brian SVP & General Counsel | 240,000 | $0 | 240,000 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:11 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer | 74,883 | $0 | 88,483 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:10 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 62,400 | $0 | 65,848 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:09 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 74,883 | $0 | 96,961 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:09 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | North Annette EVP & General Counsel | 74,883 | $0 | 86,579 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:08 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP & Chief Medical Officer | 102,350 | $0 | 109,188 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:07 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 287,040 | $0 | 334,970 (Direct) | View |
| 2021-08-30 Exercise | 2021-08-31 5:26 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. | 10,000 | $17 | 156,974 (Direct) | View |
| 2021-08-30 Exercise | 2021-08-31 5:26 pm | N/A 2029-04-14 | Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. | 10,000 | $0 | 156,974 (Direct) | View |
| 2021-07-26 Option Award | 2021-07-27 6:22 pm | N/A 2031-07-25 | Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer | 74,800 | $0 | 74,800 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-16 5:16 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. | 15,000 | $17 | 166,974 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-16 5:16 pm | N/A 2029-04-14 | Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. | 15,000 | $0 | 166,974 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:44 pm | N/A 2031-06-01 | Turning Point Therapeutics Inc. | TPTX | George Simeon Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:41 pm | N/A 2031-06-01 | Turning Point Therapeutics Inc. | TPTX | Machado Patrick Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:39 pm | N/A 2031-06-01 | Turning Point Therapeutics Inc. | TPTX | Gallagher Carol Giltner Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:37 pm | N/A 2031-06-01 | Turning Point Therapeutics Inc. | TPTX | Nicholson Garry A Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:34 pm | N/A 2031-06-01 | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 209 | $0 | 209 (Direct) | View |
| 2021-05-24 Option Award | 2021-05-26 4:50 pm | N/A 2031-05-23 | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2021-05-06 Exercise | 2021-05-07 4:37 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. | 5,882 | $17 | 181,974 (Direct) | View |
| 2021-05-06 Exercise | 2021-05-07 4:37 pm | N/A 2029-04-14 | Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. | 5,882 | $0 | 181,974 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-01 9:01 pm | N/A 2031-03-30 | Turning Point Therapeutics Inc. | TPTX | Bodem Barbara W. Director | 14,995 | $0 | 14,995 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. | 10,688 | $7.43 | 32,443 (Direct) | View |
| 2021-03-22 Option Award | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. | 1,625 | $0 | 32,443 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. | 1,298 | $3.2 | 32,443 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-24 9:54 pm | N/A 2027-08-08 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. | 28,435 | $0 | 32,443 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. | 11,904 | $2.19 | 32,443 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. | 4,545 | $5.12 | 32,443 (Direct) | View |